SeeThruEquity
Upgrades RXMD Price Target to $0.35 per
Share
Miami, FL -- March 9, 2018
InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB:
RXMD), a healthcare services and technology company, announces
upgraded price target to $0.35 per share from
SeeThruEquity.
SeeThruEquity, a premier
small and microcap research firm, released an updated analyst
report today upgrading Progressive Care's price target to $0.35 per
share. The upgrade is based on recent news of the Company's intent
to acquire a pharmacy in Palm Beach County as well as increased
sales, new product and technology development projects, and the
acceptance Bitcoin. SeeThruEquity's report issues analysis on the
Company's current business and releases new sales targets which
provide the basis for the upgraded price target for
RXMD.
https://finance.yahoo.com/news/seethruequity-issues-progressive-care-inc-131500911.html
"We are excited to see
that SeeThruEquity has initiated updated coverage of the Company,"
stated S. Parikh Mars, CEO. "We believe that we are executing on
our objectives as we take the Progressive Care to the next level.
We are humbled by the response to our story and remain focused on
delivering results to our patients and shareholders
alike."
Get connected and stay in
touch with us on social media:
Progressive Care
Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive
Care
Progressive Care Inc.
(OTCQB:RXMD),
through its subsidiaries Smart Medical Alliance, Inc. and PharmCo,
LLC, is a South Florida health services organization and provider
of prescription pharmaceuticals, compounded medications, provider
of tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long term care facilities, administration and
practice management, utilization management, quality assurance, EHR
Implementation, billing and coding, and health practice risk
management.
Cautionary Statement
Regarding Forward Looking Statements
Statements contained
herein that are not based upon current or historical fact are
forward-looking in nature and constitute forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such
forward-looking statements reflect the Company's expectations about
its future operating results, performance and opportunities that
involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen
Karapetyan
Senior Advisor Business
Development
armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com